In line with this, inhibition of mTORC1 led to a significantly downregulated expression of ERO1α in the PDAC cells PANC-1 and the breast cancer cells MDA-MB-231 (Supplementary Fig. 8C, D). The gene discussed is ERO1A; the disease is breast carcinoma.